State Of Wisconsin Investment Board Verastem, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $241,740 - $433,710	-237,000 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$1.15 - $2.4 $272,550 - $568,800	237,000 New	237,000 $505,000
Q3 2019 Nov 12, 2019	SELL	$1.21 - $1.59 $114,224 - $150,096	-94,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.25 - $3.14 $2,625 - $6,594	2,100 Added 2.28%	94,400 $143,000
Q1 2019 May 13, 2019	BUY	$2.79 - $4.09 $58,869 - $86,299	21,100 Added 29.63%	92,300 $273,000
Q4 2018 Feb 11, 2019	BUY	$3.23 - $7.01 $53,295 - $115,665	16,500 Added 30.16%	71,200 $239,000
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $375,242 - $545,359	54,700 New	54,700 $397,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $840M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.